Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Novartis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.

Novartis

Novartis, Molecular Partners launch global study of novel COVID-19 drug

Novartis, Molecular Partners launch global study of novel COVID-19 drug In October 2020, Novartis announced its collaboration with Molecular Partners, which included access to two anti-COVID-19 drugs, ensovibep and MP0423. ... Novartis will also seek a US Food and Drug Administration (FDA) emergency use authorisation

BeiGene, Novartis' tislelizumab report promising topline results in nasopharyngeal cancer

BeiGene, Novartis' tislelizumab report promising topline results in nasopharyngeal cancer Chinese pharma company BeiGene and Novartis' PD-1 inhibitor tislelizumab, combined with chemotherapy, improved progression-free survival (PFS) when administered in the first-line setting for patients with metastatic nasopharyngeal cancer

Sandoz reveals antibiotic manufacturing expansion plans in Europe

Sandoz reveals antibiotic manufacturing expansion plans in Europe Novartis’ generics division Sandoz is planning to expand its antibiotics manufacturing network by boosting its production capabilities in Austria and Spain.

US Supreme Court rebuffs Sandoz’s Enbrel biosimilar patent case

US Supreme Court rebuffs Sandoz’s Enbrel biosimilar patent case The US supreme court has decided not to review a patent case brought forward by Novartis’ generics division Sandoz for its Enbrel biosimilar Erelzi.

New court filing alleges Sanofi destroyed emails relating to Zantac recall

New court filing alleges Sanofi destroyed emails relating to Zantac recall Sanofi, along with other drugmakers manufacturing Zantac including GlaxoSmithKline and Novartis, began recalling the over-the-counter medication in 2019 following concerns that the drug contained a potentially cancer-causing impurity.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...